1324 related articles for article (PubMed ID: 31797045)
21. Clinical utility of circulating tumor DNA for colorectal cancer.
Osumi H; Shinozaki E; Yamaguchi K; Zembutsu H
Cancer Sci; 2019 Apr; 110(4):1148-1155. PubMed ID: 30742729
[TBL] [Abstract][Full Text] [Related]
22. Liquid biopsy for precision diagnostics and therapeutics.
Anitha K; Posinasetty B; Naveen Kumari K; Chenchula S; Padmavathi R; Prakash S; Radhika C
Clin Chim Acta; 2024 Feb; 554():117746. PubMed ID: 38151071
[TBL] [Abstract][Full Text] [Related]
23. Circulating Tumor DNA as a Biomarker for Outcomes Prediction in Colorectal Cancer Patients.
Petrillo A; Salati M; Trapani D; Ghidini M
Curr Drug Targets; 2021; 22(9):1010-1020. PubMed ID: 33155906
[TBL] [Abstract][Full Text] [Related]
24. Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.
Hicks JK; Saller J; Wang E; Boyle T; Gray JE
Lung Cancer; 2017 Sep; 111():135-138. PubMed ID: 28838384
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.
Onidani K; Shoji H; Kakizaki T; Yoshimoto S; Okaya S; Miura N; Sekikawa S; Furuta K; Lim CT; Shibahara T; Boku N; Kato K; Honda K
Cancer Sci; 2019 Aug; 110(8):2590-2599. PubMed ID: 31169336
[TBL] [Abstract][Full Text] [Related]
26. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.
Vymetalkova V; Cervena K; Bartu L; Vodicka P
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373199
[TBL] [Abstract][Full Text] [Related]
27. [Circulating Tumor DNA (ctDNA) Detection Using BEAMing and Its Clinical Significance.].
Nakamura K
Rinsho Byori; 2016 May; 64(4):400-406. PubMed ID: 29182806
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients.
Yang YC; Wang D; Jin L; Yao HW; Zhang JH; Wang J; Zhao XM; Shen CY; Chen W; Wang XL; Shi R; Chen SY; Zhang ZT
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29914973
[TBL] [Abstract][Full Text] [Related]
29. Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients.
Crisafulli G; Mussolin B; Cassingena A; Montone M; Bartolini A; Barault L; Martinetti A; Morano F; Pietrantonio F; Sartore-Bianchi A; Siena S; Di Nicolantonio F; Marsoni S; Bardelli A; Siravegna G
ESMO Open; 2019 Nov; 4(6):. PubMed ID: 32149725
[TBL] [Abstract][Full Text] [Related]
30. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
[TBL] [Abstract][Full Text] [Related]
31. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.
Venesio T; Siravegna G; Bardelli A; Sapino A
Pathobiology; 2018; 85(1-2):146-154. PubMed ID: 28614831
[TBL] [Abstract][Full Text] [Related]
32. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.
Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP
Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114
[TBL] [Abstract][Full Text] [Related]
33. Role of Circulating Tumor DNA in Colorectal Cancer.
Li H; Lu S; Zhou Z; Zhu X; Shao Y
Methods Mol Biol; 2023; 2695():227-236. PubMed ID: 37450122
[TBL] [Abstract][Full Text] [Related]
34. The Introduction and Clinical Application of Cell-Free Tumor DNA.
Li J; Liu R; Huang C; Chen S; Xu M
Methods Mol Biol; 2018; 1754():45-65. PubMed ID: 29536437
[TBL] [Abstract][Full Text] [Related]
35. Rapid Multiplex Strip Test for the Detection of Circulating Tumor DNA Mutations for Liquid Biopsy Applications.
Kalligosfyri PM; Nikou S; Karteri S; Kalofonos HP; Bravou V; Kalogianni DP
Biosensors (Basel); 2022 Feb; 12(2):. PubMed ID: 35200357
[TBL] [Abstract][Full Text] [Related]
36. Utility of circulating tumor cells and DNA in the management of advanced colorectal cancer.
Pan X; Zhang X
Future Oncol; 2020 Jun; 16(18):1289-1299. PubMed ID: 32379501
[No Abstract] [Full Text] [Related]
37. Clinical application of circulating tumour DNA in colorectal cancer.
Loft M; To YH; Gibbs P; Tie J
Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):837-852. PubMed ID: 37499673
[TBL] [Abstract][Full Text] [Related]
38. Toward liquid biopsies in cancer treatment: application of circulating tumor DNA.
Barlebo Ahlborn L; Østrup O
APMIS; 2019 May; 127(5):329-336. PubMed ID: 30784124
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumor DNA sequencing for colorectal cancers: A comparative analysis of colon cancer and rectal cancer data.
Huang K; Qu H; Zhang X; Huang T; Sun X; He W; Li M; Lin L; Xu M; Chen S; Xia L
Cancer Biomark; 2019; 26(3):313-322. PubMed ID: 31561327
[TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing.
Iwahashi N; Sakai K; Noguchi T; Yahata T; Matsukawa H; Toujima S; Nishio K; Ino K
Sci Rep; 2019 Jul; 9(1):10426. PubMed ID: 31320709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
